Med BioGene | GenomeWeb

Med BioGene

The firms have eliminated several terms of their original deal and have cross-licensed IP to allow Med BioGene to license Gene FX Lung to other firms. 

NEW YORK (GenomeWeb) – Med BioGene today announced that it is ready to initiate proceedings against its commercial partner Precision Therapeutics to enforce a C$1 million (US$920,000) milestone payment due to Med BioGene.

NEW YORK (GenomeWeb News) – Med BioGene today said that its commercial partner, Precision Therapeutics, has been certified to perform Med BioGene's lung cancer test out of Precision's Pittsburgh laboratory.

NEW YORK (GenomeWeb News) – Signal Genetics and its subsidiary Respira Health have withdrawn and dismissed their lawsuit against Med BioGene and its commercial partner Precision Therapeutics.

NEW YORK (GenomeWeb News) – Life Technologies said this week that it has opened up a 'Customer Experience Centre' in Russia in collaboration with one of its distributors, Khimexpert.

NEW YORK (GenomeWeb News) – Med BioGene today reported a second quarter net loss of C$139,171 (US$132,159), up slightly from a net loss of C$102,121 for the second quarter of 2012.

NEW YORK (GenomeWeb News) – Med BioGene today said that it and its commercial partner, Precision Therapeutics, have settled litigation with Signal Genetics and its Respira Health subsidiary, ending a dispute over an alleged breach of contract that began more than two years ago.

NEW YORK (GenomeWeb News) – Med BioGene today reported no revenues for the first quarter, the same as in the first quarter of 2012.

NEW YORK (GenomeWeb News) – Med BioGene had no revenues and a loss of $366,345, or breakeven on a per-share basis, for full-year 2012, the company disclosed in a document filed with Canadian regulators today.

NEW YORK (GenomeWeb News) – SynapDx this week said that it has received a "significant investment" from The Kraft Group that will support ongoing clinical development of its molecular diagnostic test for autism spectrum disorder.

Pages

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.